ARTIVION, INC. AORT
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1993-02-12
ARTIVION, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| Operating margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| Net margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% |
| FCF margin | 0.2% | 2.8% | 2.6% | -5.1% | -5.2% |
| Return on assets | 1.1% | -1.7% | -3.9% | -2.5% | -1.9% |
| Return on equity | 2.2% | -4.8% | -10.9% | -6.7% | -4.9% |
| Debt / equity | 0.48× | 1.14× | 1.09× | 1.08× | 1.03× |
| Current ratio | 3.53 | 4.34 | 4.85 | 4.98 | 5.51 |
| Revenue growth | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% |
Source: SEC EDGAR filings · CIK 0000784199 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.